RNAi-induced down-regulation of Mecp2 expression in the rat brain

International Journal of Developmental Neuroscience

Volumn 26, Issue 5, 2008, Pages 457-465

  Jin, Jing ^a   Bao, Xinhua ^a   Wang, Hansen ^a   Pan, Hong ^a   Zhang, Yuzhi ^a   Wu, Xiru ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

Brain; Cerebral cortex; Hippocampus; Lentiviral vector; Methyl CpG binding protein 2; Neonatal rat; Small hairpin RNA (shRNA)

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; LENTIVIRUS VECTOR; METHYL CPG BINDING PROTEIN 2; RNA; SHORT HAIRPIN RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DOWN REGULATION; GENE TARGETING; HIPPOCAMPUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SENSORIMOTOR FUNCTION;

ANIMALS; ANIMALS, NEWBORN; BASE SEQUENCE; BEHAVIOR, ANIMAL; BLOTTING, WESTERN; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELLS, CULTURED; CEREBRAL CORTEX; DOWN-REGULATION; ENCEPHALITIS; FIBROBLASTS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HIPPOCAMPUS; INJECTIONS, INTRAVENTRICULAR; LENTIVIRUS; METHYL-CPG-BINDING PROTEIN 2; MOLECULAR SEQUENCE DATA; PSYCHOMOTOR PERFORMANCE; RATS; RETT SYNDROME; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE;

LENTIVIRUS; RATTUS;

EID: 43049153237     PISSN: 07365748     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2008.02.009     Document Type: Article

References (33)

1. Alsina B., Vu T., and Cohen-Cory S. Visualizing synapse formation in arborizing optic axons in vivo: dynamics and modulation by BDNF. Nat. Neurosci. 4 (2001) 1093-1101
2. Amaral M.D., Chapleau C.A., and Pozzo-Miller L. Transient receptor potential channels as novel effectors of brain-derived neurotrophic factor signaling: potential implications for Rett syndrome. Pharmacol. Ther. 113 (2007) 394-409
3. Amir R.E., Van den Veyver I.B., Wan M., Tran C.Q., Francke U., and Zoghbi H.Z. Rett syndrome is caused by mutations in X-linked MeCP2, encoding methyl-CpG-binding protein 2. Nat. Genet. 23 (1999) 185-188
4. Armstrong D.D. Review of Rett syndrome. J. Neuropathol. Exp. Neurol. 56 (1997) 843-849
5. Armstrong D., Dunn J.K., Antalffy B., and Trivedi R. Selective dendritic alterations in the cortex of Rett syndrome. J. Neuropathol. Exp. Neurol. 54 (1995) 195-201
6. Balichenko P.V., Hagberg B., and Dahlstrom A. Morphological study of neocortical areas in Rett syndrome. Acta Neuropathol. 93 (1997) 50-61
7. Barton G.M., and Medzhitov R. Retroviral delivery of small interfering RNA into primary cells. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 14943-14945
8. Chang Q., Khare G., Dani V., Nelson S., and Jaenisch R. The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression. Neuron 49 (2006) 341-348
9. Chen R.Z., Akbarian S., Tudor M., and Jaenisch R. Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett like phenotype in mice. Nat. Genet. 27 (2001) 327-331
10. Chen W.G., Chang Q., Lin Y., Meissner A., West A.E., Griffith E.C., Jaenisch R., and Greenberg M.E. Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science 302 (2003) 885-889
11. Colantuoni C., Jeon O.H., Hyder K., Chenchik A., Khimani A.H., Narayanan V., Hoffman E.P., Kaufmann W.E., Naidu S., and Pevsner J. Gene expression profiling in postmortem Rett syndrome brain: differential gene expression and patient classification. Neurobiol. Dis. 8 (2001) 847-865
12. De Bona C., Zappella M., Hayek G., Meloni I., Vitelli F., Bruttini M., Cusano R., Loffredo P., Longo I., and Renieri A. Preserved speech variant is allelic of classic Rett syndrome. Eur. J. Hum. Genet. 8 (2000) 325-330
13. Deng V., Matagne V., Banine F., Vivianne Deng, Valerie Matagne, Fatima Banine, Frerking M., Ohliger P., Budden S., Pevsner J., Dissen G.A., Sherman L.S., and Ojeda S.R. FXYD1 is a MeCP2 target gene overexpressed in the brains of Rett syndrome patients and Mecp2-null mice. Hum. Mol. Genet. 16 (2007) 640-650
14. Einspieler C., Kerr A.M., and Prechtl H.F. Is the early development of girls with Rett disorder really normal?. Pediatr. Res. 57 (2005) 696-700
15. Fire A., Xu S., Montgomery M.K., Kostas S.A., Driver S.E., and Mello C.C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391 (1998) 806-811
16. Fox M.W. Reflex-ontogeny and behavioral development of the mouse. Anim. Behav. 13 (1965) 234-241
17. Guy J., Hendrich B., Holmes M., Martin J.E., and Bird A. A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat. Genet. 27 (2001) 322-326
18. Horike S., Cai S., Miyano M., Cheng J.F., and Kohwi-Shigematsu T. Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome. Nat. Genet. 37 (2005) 31-40
19. Jellinger K., Armstrong D., Zoghbi H.Y., and Percy A.K. Neuropathology of Rett syndrome. Acta Neuropathol. 76 (1988) 142-158
20. Kriaucionis S., and Bird A. The major form of MeCP2 has a novel N-terminus generated by alternative splicing. Nucleic Acids Res. 32 (2004) 1818-1823
21. Lom B., and Cohen-Cory S. Brain-derived neurotrophic factor differentially regulates retinal ganglion cell dendritic and axonal arborization in vivo. J. Neurosci. 19 (1999) 9928-9938
22. Martinowich K., Hattori D., Wu H., Fouse S., He F., and Hu Y. DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science 302 (2003) 890-893
23. Mnatzakanian G.N., Lohi H., Munteanu I., Alfred S.E., Yamada T., MacLeod P.J., Jones J.R., Scherer S.W., Schanen N.C., Friez M.J., Vincent J.B., and Minassian B.A. A previously unidentified MECP2 open reading frame defines a new protein isoform relevant to Rett syndrome. Nat. Genet. 36 (2004) 339-341
24. Mourrain P., Beclin C., Elmayan T., Feuerbach F., Godon C., Morel J.B., Jouette D., Lacombe A.M., Nikic S., Picault N., Remoue K., Sanial M., Vo T.A., and Vaucheret H. Arabidopsis SGS2 and SGS3 genes are required for posttranscriptional gene silencing and natural virus resistance. Cell 101 (2000) 533-542
25. Peddada S., Yasui D.H., and LaSalle J.M. Inhibitors of differentiation (ID1, ID2, ID3 and ID4) genes are neuronal targets of MeCP2 that are elevated in Rett syndrome. Hum. Mol. Genet. 15 (2006) 2003-2014
26. Percy A.K., and Lane J.B. Rett syndrome: clinical and molecular update. Curr. Opin. Pediatr. 16 (2004) 670-677
27. Picker J.D., Yang R., Ricceri L., and Berger-Sweeney J. An altered neonatal behavioral phenotype in Mecp2 mutant mice. Neuroreport 17 (2006) 541-544
28. Renieri A., Meloni I., Longo I., Ariani F., Mari F., Pescucci C., and Cambi F. Rett syndrome: the complex nature of a monogenic disease. J. Mol. Med. 81 (2003) 346-354
29. Rubinson D.A., Dillon C.P., Kwiatkowski A.V., Sievers C., Yang L., Kopinja J., Rooney D.L., Zhang M., Ihrig M.M., McManus M.T., Gertler F.B., Scott M.L., and Van Parijs L. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat. Genet. 33 (2003) 401-406
30. Shahbazian M.D., and Zoghbi H.Y. Molecular genetics of Rett syndrome and clinical spectrum of MECP2 mutations. Curr. Opin. Neurol. 14 (2001) 171-176
31. Subramaniam B., Naidu S., and Reiss A.L. Neuroanatomy in Rett syndrome: cerebral cortex and posterior fossa. Neurology 48 (1997) 399-407
32. Tabara H., Sarkissian M., Kelly W.G., Fleenor J., Grishok A., Timmons L., Fire A., and Mello C.C. The rde21 gene, RNA interference, and transposon silencing in C. elegans. Cell 99 (1999) 123-132
33. Yacoubian T.A., and Lo D.C. Truncated and full-length TrkB receptors regulate distinct modes of dendritic growth. Nat. Neurosci. 3 (2000) 342-349